This also increases the reservoir of undiagnosed infection and emphasises the importance screening high risk populations.
Syphilis RPR
Syphilis RPR
The incidence of syphilis in the European Union increased since 2000 with the most significant increase among men who have sex with men (MSM).
Syphilis is a complex, multistage disease caused by Treponema pallidum. When left untreated, syphilis can result in severe cardiovascular, ocular and neurological complications. Infectious syphilis is also associated with an increased risk of HIV transmission.
Serologic testing to diagnose syphilis includes the use of both nontreponemal and treponemal tests. Initial screening is usually carried out using a treponemal test with confirmation using a non-treponemal option such as the rapid plasma reagin (RPR) test. RPR usually become positive approximately 10-15 days after the appearance of the primary chancre (i.e. around 6 weeks after infection). RPR titres correlate grossly with disease activity and are used to monitor both disease activity and efficacy of treatment.
Case Study
Delivering True Innovation
Our Services
5mL venous serum or plasma OR 0.8mL capillary serum.
Enfer Medical
Tests/Assays
Enfer Medical offers the Non-treponemal test which measures the host’s antibody response to non-treponemal antigens. Rapid plasma regain (RPR) provides a qualitative and semi-quantitative measurement of non-treponemal syphilis-associated antibodies (reagin) in human serum and plasma as an aid in the diagnosis in syphilis infection. This test is CE-IVD certified.
Patient
Request Form
For clients using the Enfer Medical Client Portal, the Enfer Medical Patient Request Form (PRF) will be generated when you have completed your “Test Request” within the portal linked below.
Please note that samples suspected of containing high risk pathogens such as Mycobacterium tuberculosis should be clearly identified on the form and packed separately from other samples.
Results are available next working day.
This assay is available seven days a week.
Packaging
The packaging/preparation of samples for delivery to the laboratory are required to be in adherence to all national regulations for the safe transport of biological materials. HSE guidance can be reviewed HERE.
There are specific packaging instructions and labelling requirements requiring triple packaging including:
- Primary leak-proof container – tube or vial containing the sample.
- Secondary watertight container, with absorbent material, intended to protect the primary container.
- Outer container protects the secondary container.
- Patient Request forms must be placed between the secondary container and the outer shipping container.
Further information on the packaging/preparation of samples for delivery to the laboratory is contained within the Enfer Medical Laboratory User Manual which clients are provided with.
Storage & Stability
Samples must be tested within 7 days of collection and stored between 2-8°C.
Samples
In addition to the packaging of samples, the transport/delivery of clinical samples to the laboratory is required to be in adherence to all national regulations for the safe transport of biological materials. Enfer Medical provides a fully compliant logistics service, aligned with clients’ testing requirements.
Prompt transport of specimens:
To ensure prompt testing of samples and release of results within the published test turnaround times, samples should arrive to the laboratory by 18:00. Test turnaround time is measured from receipt of the sample at the laboratory until the time the authorised results are reported to users.
of Samples
In rare cases specimens may not be suitable for testing on arrival to the laboratory. In that case the sample will be rejected at the receipt stage and the service user will be notified immediately and an explanation as to why the sample could not be processed will be provided. Reasons why samples cannot be processed include but are not limited to:
- Samples received beyond the stability limits and/or not at the correct temperature indicated for each test.
- Incorrect sample type received.
- Leaking samples, sample not received or sample insufficient for analysis as stated below within sample requirements.
- Non-compliant samples or request forms i.e. those missing sample date information, missing sample test request and/or missing sample site/type information.
- Samples received without the necessary patient identifiers.
Our Services
- DETECTED (TITRE e.g. 1:16)
- NOT DETECTED
- EQUIVOCAL
Please note that Syphilis is a notifiable disease under the Infectious Diseases (Amendment) Regulations 2020 (S.I. No. 53 of 2020) February 2020. Please refer to the Health Protection Surveillance Centre for the Case Definitions for Notifiable Diseases:
Accessing
Your Results
Following receipt at the Laboratory, results should be available on the next working day and will be reported to the referring clinician via the Enfer Medical Client Portal or in a format agreed with clients.
Established clients can login to the portal using the link above.